Ease of administration and dual protection can drive novel intranasal vaccine adoption: GlobalData
Late-stage clinical trials of intranasal COVID-19 vaccines are expected to begin in India in the coming months
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.